Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 493 followers
Latest posts
Last updated 25 days ago
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ekterly, sebetralstat, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Ekterly, sebetralstat, Status: Opinion
Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Status: Opinion
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Status: Opinion
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes...
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion
Human medicines European public assessment report (EPAR): Macitentan AccordPharma, macitentan, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Macitentan AccordPharma, macitentan, Status: Opinion
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Status: Opinion
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Opinion
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Status: Opinion